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Background: Randomized controlled trials (RCTs) often provide accurate estimates of the internal validity of an intervention
but lack information on external validity (generalizability). We conducted an RCT on the effectiveness of a self-management
intervention among patients with lymphoma in a population-based setting.
Objective: The objectives of the current study were to describe the proportion of RCT participants compared to all patients
invited to participate, and compare sociodemographic and clinical characteristics of RCT participants with all respondents, all
patients invited to participate, and all patients selected from the Netherlands Cancer Registry (NCR) to determine the reach of
the intervention. An additional objective was to assess differences on RCT outcome variables between RCT and paper respondents.
Methods: Patients with lymphoma or chronic lymphocytic leukemia ≥18 years old at diagnosis from 13 hospitals in the
Netherlands were selected from the population-based NCR, which routinely collects data on sociodemographic and clinical
characteristics. Eligible patients were invited to participate in an RCT and complete a questionnaire. Web-based completion
determined RCT enrollment, whereas paper respondents were followed observationally.
Results: A total of 1193 patients were selected from the NCR, 892 (74.77%) of whom were invited to participate in the trial by
their hematologist after verifying eligibility. Among those invited, 25.4% (227/892) completed the web-based questionnaire and
were enrolled in the RCT. The RCT participants were younger and there was a higher proportion of men than nonparticipants
(P<.001). In addition, 25.7% (229/892) of those invited opted to participate in the paper-based observational follow-up study.
Compared with paper respondents, RCT participants were younger (P<.001), with a higher proportion of men (P=.002), and had
higher education levels (P=.02). RCT participants more often wanted to receive all available information on their disease (P<.001),
whereas paper respondents reported higher levels of emotional distress (P=.009).
Conclusions: From a population-based sample of eligible patients, the participation rate in the RCT was approximately 25%.
RCT participants may not be representative of the target population because of different sociodemographic and clinical
characteristics. Since RCT participants represent a minority of the target population, RCT results should be interpreted with
caution as patients in the RCT may be those least in need of a self-management intervention.
J Med Internet Res 2020 | vol. 22 | iss. 5 | e17018 | p. 1http://www.jmir.org/2020/5/e17018/
(page number not for citation purposes)
Arts et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Trial Registration: Netherlands Trial Register NTR5953; https://www.trialregister.nl/trial/5790
(J Med Internet Res 2020;22(5):e17018) doi: 10.2196/17018
KEYWORDS
reach; uptake; participation, web-based intervention; pragmatic; randomized controlled trial; population-based registry; lymphoma
Introduction
Randomized controlled trials (RCTs) are widely considered to
be the gold standard for evaluating the effects of an intervention
in behavioral and psycho-oncological research [1,2]. In contrast
to the effects of interventions that are most often examined
extensively in RCTs [3], much less attention has been paid to
the proportion of patients who participate in these interventions
and whether those who choose to participate are representative
of the target population in terms of sociodemographic and
clinical characteristics [2,4]. Thus, RCTs often provide accurate
estimates of the internal validity (ie, effect of an intervention
for the sample enrolled in the RCT), but do not typically provide
information about the external validity or generalizability (ie,
effect of an intervention in the target population) [5-7].
The reach of an RCT provides information on the absolute
number, proportion, and representativeness of the sample that
participates in the trial [8]. The absolute number and proportion
of RCT participants are relatively easy to assess and are
therefore most often reported. However, few studies report the
representativeness of the sample enrolled in an RCT, which is
a much more challenging metric to assess [8,9] since it requires
sociodemographic information, and preferable psychosocial,
clinical, or case mix information, on RCT participants as well
as nonparticipants. It is particularly challenging to collect
information on nonparticipants who typically do not consent to
be included in the research [8].
Interventions with promising effects in RCTs have been
implemented in daily practice without specific knowledge of
the generalizability of the results. Therefore, more attention
should be paid to providing information related to the
representativeness of the sample enrolled in an RCT. Lack of
representativeness may occur as a result of inadequate selection
procedures (ie, sampling bias) or when the probability of
nonparticipation in the study is related to the object of research
(ie, nonresponse bias) [10,11].
To fill this gap, the aim of the current study was to address the
reach of a web-based self-management intervention within the
context of the Lymphoma InterVEntion (LIVE) trial
(Netherlands Trial Register NTR5953), whose objectives have
been described elsewhere [12]. For the LIVE trial, patients were
selected from the population-based Netherlands Cancer Registry
(NCR) that routinely collects data on sociodemographic and
clinical characteristics. This can provide unique insight into the
characteristic differences between RCT participants and
nonparticipants to estimate the reach of this intervention. The
primary objectives were to (1) describe the proportion of RCT
participants compared to all patients invited to participate, and
(2) compare sociodemographic and clinical characteristics of
RCT participants with those of all respondents (ie, patients who
completed a web-based or paper questionnaire), all patients
invited to participate, and all patients selected from the NCR.
In addition, as patients had the option of completing a web-based
questionnaire (ie, enrollment in the RCT) or a paper-based
questionnaire (ie, no enrollment in the RCT; observational
cohort), a secondary objective was to assess baseline differences
in psychological distress, self-management skills, and
satisfaction with information provision (ie, RCT outcome
variables) between the two groups.
Methods
Study Design
Baseline data were collected from an RCT embedded in a
population-based registry [13] as an observational
cross-sectional dataset without information on the effectiveness
of the intervention. In short, the LIVE trial examines the
effectiveness of feedback on patient-reported outcomes and a
web-based self-management intervention on self-management
skills, satisfaction with information provision, and psychological
distress among patients with lymphoma [12].
Participants and Recruitment Procedure
From October 2016 to February 2019, patients who were
diagnosed with lymphoma, including Hodgkin lymphoma,
nonHodgkin lymphoma, or chronic lymphocytic leukemia (CLL)
as defined by the International Classification of Diseases for
Oncology-3 codes [14], from 13 hospitals in the Netherlands
were selected for participation via the NCR. The NCR registers
all patients newly diagnosed with cancer in the Netherlands
within the first year after diagnosis and routinely collects
detailed data on sociodemographic and clinical characteristics
(eg, patient age and sex, date of cancer diagnosis, cancer type,
and primary treatment). Patients had to be 18 years or older at
the time of study invitation. Treating hematologists were asked
to verify the patients’ eligibility for the study and to exclude
patients who were deceased, had severe psychopathology, were
too ill, were not able to complete a questionnaire in Dutch, or
had severe cognitive impairment. All eligible patients were
invited by mail to participate by their own hematologist. Patients
had the option to complete a web-based or paper-based
questionnaire. Patients were informed that completion of the
web-based questionnaire automatically resulted in enrollment
in the RCT with randomization to one of the study arms,
whereas completion of a paper questionnaire resulted in
participation in the observational Patient Reported Outcomes
Following Initial treatment and Long term Evaluation of
Survivorship (PROFILES) registry [13] but not enrollment in
the RCT. To address the primary objective of the current
study—describing the proportion of RCT participants compared
to all patients invited to participate—paper respondents were
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assessed as nonparticipants as they did not participate in the
RCT.
Measures
Sociodemographic and Clinical Measures
Sociodemographic characteristics (age and sex) and detailed
clinical information (date of diagnosis, cancer type, primary
treatment) were available from the NCR. Information on
education level and marital status was assessed from the
questionnaire (data only available for respondents).
Comorbidities at the time of questionnaire completion were
assessed using an adapted version of the self-administered
comorbidity questionnaire [15]. Patients were asked to identify
comorbidities present within the past 12 months, including heart
disease, hypertension, arthritis, stroke, lung disease, diabetes,
stomach disease, kidney disease, liver disease, anemia, thyroid
disease, and rheumatoid arthritis. Positive responses were
summed to a total score ranging from 0 to 12 (data only
available for respondents).
Personality Traits
Personality traits were assessed with the Big Five Inventory, a
44-item inventory designed to measure the Big Five dimensions
of personality: extraversion, neuroticism, conscientiousness,
agreeableness, and openness to experience [16]. Each item was
scored on a 5-point scale. Scale scores were obtained by
averaging all items for each domain ranging from 0 to 5. Each
trait is assumed to represent a continuum from high to low on
the specific attribute and is partnered with a trait on the opposite
pole of the spectrum [17,18].
Information Preferences
One question from an adapted version of the Information
Satisfaction Questionnaire was used to measure information
preferences [19]. Patients had to categorize themselves into one
of three groups: those who would like (1) all available
information, (2) only positive information about the illness, and
(3) only limited information. Patients were further asked whether
they use the internet (yes/no).
Psychological Distress, Self-Management Skills, and
Satisfaction With Information Provision
Primary outcomes to assess the effectiveness of the intervention
were psychological distress, self-management skills, and
satisfaction with information provision.
Psychological distress was assessed with the 14-item Hospital
Anxiety and Depression Scale [20]. Each item is rated on a
4-point scale from 0 to 3. The total score was obtained by adding
all item scores and ranged from 0 to 42, in which higher scores
indicate higher levels of psychological distress [21]. Patients
with a Hospital Anxiety and Depression Scale sum score ≥13
were categorized as “psychologically distressed” [22].
Self-management skills were assessed with the Health Education
Impact Questionnaire (heiQ) that contains 40 items across eight
scales: positive and active engagement in life, health-directed
activities, skill and technique acquisition, constructive attitudes
and approaches, self-monitoring and insight, health service
navigation, social integration and support, and emotional distress
[23]. Each item is scored on a 4-point scale. Scale scores were
obtained by averaging all items for each domain and ranged
from 1 to 4. Higher scores indicate better status or
self-management, except for emotional distress in which higher
scores indicate greater distress [23].
Satisfaction with overall information provision was assessed
with one item from an adapted version of the Information
Satisfaction Questionnaire [19]. Patients were asked to rate their
level of satisfaction for overall information provision on a scale
from 1 (“very unsatisfied”) to 5 (“very satisfied”).
Statistical Analyses
The proportion of RCT participants (ie, participation rate) was
calculated by dividing the number of patients who were enrolled
in the RCT by the total number of eligible patients who were
invited to participate. Sociodemographic and clinical
characteristics of RCT participants were compared with those
of all respondents (ie, patients who completed a web-based or
paper questionnaire), all patients invited to participate, and all
patients selected from the population-based NCR. In addition,
personality traits and information preferences of RCT
participants were compared with those of all respondents.
Differences on sociodemographic and clinical characteristics
between RCT participants and nonparticipants were compared
using analysis of variance for continuous variables and
Chi-square tests for categorical variables.
Differences in baseline psychological distress, self-management
skills, and satisfaction with information provision (ie, RCT
outcome variables) between RCT participants and paper
respondents were compared using analysis of variance for
continuous variables and Chi-square tests for categorical
variables. All statistical analyses were performed with SAS
version 9.4 (Cary, NC, USA). P≤.05 indicated statistically
significant differences.
Results
Patients Selected From the Netherlands Cancer
Registry
As shown in Figure 1, a total of 1193 patients with lymphoma
or CLL who were ≥18 years old at diagnosis from 13 hospitals
were selected from the population-based NCR. The basic
characteristics of the invited patients are summarized in Table
1. The majority of patients were men, were diagnosed with
high-grade nonHodgkin lymphoma, and were actively being
treated, with chemotherapy as the most common treatment.
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Figure 1. Flowchart of the data collection process. CLL: chronic lymphocytic leukemia; NCR: Netherlands Cancer Registry; RCT: randomized
controlled trial; PROFILES: Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship.
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Patients selected from the
NCR (N=1193)
Characteristic
Sociodemographic characteristics, n (%)
60.7 (13.4)64.5 (13.5)64.1 (15.3)64.7 (15.6)Age at time of survey (years), mean (SD)
Sex, n (%)
161 (70.9)291 (63.8)537 (60.2)725 (60.8)Male





190 (83.7)355 (77.9)N/AN/APartner (yes), n (%)
Clinical characteristics
14.0 (3.2)14.2 (3.3)14.0 (3.4)13.9 (3.5)Months since diagnosis, mean (SD)
Cancer type, n (%)
27 (11.9)46 (10.1)102 (11.4)120 (10.1)HLg
125 (55.1)260 (57.0)484 (54.3)676 (56.7)NHL-HGh
56 (24.7)114 (25.0)224 (25.1)280 (23.5)NHL-LGi
19 (8.4)36 (7.9)82 (9.2)116 (9.7)CLLj
Primary treatment, n (%)
53 (23.3)113 (24.8)252 (28.3)315 (26.4)Active surveillance
109 (48.0)222 (48.7)405 (45.4)522 (43.8)CTk alone
11 (4.8)31 (6.8)70 (7.8)80 (6.7)RTl alone
29 (12.8)51 (11.2)90 (10.1)103 (8.6)CT + RT
16 (7.0)20 (4.4)25 (2.8)30 (2.5)SCTm/CT/ RT
7 (3.1)16 (3.5)39 (4.4)56 (4.7)Other
2 (0.9)3 (0.7)11 (1.2)87 (7.3)Unknown
1.1 (1.1)1.3 (1.2)N/AN/ANumber of self-reported comorbidities, mean (SD)






Information preferences, n (%)
126 (55.5)211 (46.3)N/AN/AAll available information
23 (10.1)65 (9.9)N/AN/AOnly positive information
78 (34.4)170 (37.3)N/AN/ALimited information
220 (96.9)370 (81.1)N/AN/AInternet use (yes)
aSee Figure 1 for the flowchart of patient selection. The groups in columns are not mutually exclusive; RCT participants are also included in the groups
of the other 3 columns.
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bRCT: randomized controlled trial.
cLow education level: none/primary school.
dN/A: data not available.
eMedium education level: lower general secondary education/vocational training.
fHigh education level: preuniversity education/high-level vocational training/university.
gHL: Hodgkin lymphoma.
hNHL-HG: high-grade nonHodgkin lymphoma.
iNHL-LG: low-grade nonHodgkin lymphoma.
jCLL: chronic lymphocytic leukemia.
kCT: chemotherapy.
lRT: radiotherapy.
mSCT: stem cell transplantation.
Patients Invited to Participate
A flowchart of the patient selection process is shown in Figure
1. Of all selected patients, 24.81% (296/1193) were excluded
after verifying eligibility by their treating hematologists for the
following reasons: deceased, severe psychopathology, too ill,
insufficient proficiency of the Dutch language, and cognitive
impairment. In addition, 156 patients were not eligible for other
reasons, including 36 patients who received treatment or follow
up in another hospital and 20 patients for whom the ultimate
diagnosis did not meet our inclusion criteria (eg, myelodysplastic
syndrome, acute lymphoblastic leukemia). The remaining 100
patients were excluded by the hematologists for unknown
reasons. Furthermore, 5 patients were excluded as they declined
participation in previous studies within the PROFILES registry.
After exclusion of these patients, 892 patients (74.77%) were
invited to participate and completed a questionnaire. Patients
invited to participate did not significantly differ from all patients
selected from the NCR in terms of age (P=.38) and sex (P=.07)
(Table 1).
Respondents
Among the 892 invited patients, 456 patients (51.1%) responded
and completed either a web-based or paper questionnaire. The
mean age of all respondents (Table 1) was comparable with that
of nonrespondents (63.8 years, P=.43), and the majority of the
respondents were also men. Respondents did not differ from all
patients selected from the NCR in terms of age (P=.81) and sex
(P=.26). Respondents were more often actively treated than
nonrespondents (75% vs 66%, P=.01). Half of the respondents
(229/456, 50.2%) completed a paper questionnaire, whereas the
other half (227/456, 49.8%) completed a web-based
questionnaire and were enrolled in the RCT. Nearly half of the
respondents stated that they would like to receive all available
information, with a lower proportion preferring limited
information, and even less indicating that they would like to
receive only positive information about the illness (Table 1).
Approximately 82% of all respondents reported using the
internet.
Randomized Controlled Trial Participants
A quarter of all invited patients (227/892) participated by
completing a web-based questionnaire, which resulted in a
participation rate of the RCT of 25.4%. The mean age of RCT
participants was slightly lower than that of nonparticipants (ie,
nonrespondents and paper respondents (n=665, 65.3 years,
P<.001) with a slightly higher mean time since diagnosis, and
comprised a higher proportion of men (70.9%, 161/227 vs
57.0%, 379/665, P<.001). The proportion of patients who were
actively treated were comparable between RCT participants and
nonparticipants (75.8%, 172/227 vs 69.0%, 459/665, P=.13).
In addition, RCT participants were significantly younger than
respondents, patients invited to participate, and patients selected
from the NCR (all P<.001). Furthermore, there was a higher
proportion of men among RCT participants compared with all
patients invited to participate and all patients selected from the
NCR (both P<.001).
Randomized Controlled Trial Participants Versus
Paper Participants
RCT participants were younger than paper respondents (60.7
vs 68.3 years, P<.001). In addition, RCT participants were more
often male (71% vs 57%, P=.002), more highly educated (50%
vs 20%, P<.001), and more often had a partner (84% vs 75%,
P=.02). No significant differences were found between RCT
and paper respondents regarding cancer type or primary
treatment (P=.54 and P=.06, respectively). RCT participants
also reported fewer comorbidities than paper respondents (1.1
vs 1.4, P=.02).
Concerning personality traits, RCT participants had lower scores
on neuroticism (2.4 vs 2.6, P=.003) and higher scores on
openness to experience (3.5 vs 3.4, P=.002) than paper
respondents, although effect sizes were small (Cohen d=0.29
and 0.28, respectively). With respect to information preferences,
the majority of RCT participants stated a preference for
receiving all available information, whereas only 38.9% (89/229)
of paper respondents indicated this preference (P=.001).
Conversely, paper respondents more often preferred receiving
limited information (41.9%, 96/227 vs 34.4%, 78/227; P=.001).
Furthermore, RCT participants more often used the internet
(96.9%, 220/227 vs 66.4%, 152/229; P<.001) (Table 1).
Emotional distress, as measured with the heiQ, was significantly
lower among RCT participants compared with the score for
paper respondents (Table 2), although the effect size was small
(Cohen d=0.25). No significant differences were observed
regarding other self-management skills between the RCT and
paper groups. In addition, no significant differences were
observed in the proportion of patients with psychological distress
between RCT participants and paper respondents, although
paper participants seemed to have higher mean scores.
Furthermore, no differences were observed between RCT
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participants and paper respondents regarding satisfaction with overall information provision (Table 2).
Table 2. Differences in randomized controlled trial (RCT) outcome variables at baseline between RCT participants and paper respondents.





.1845 (19.7)34 (15.0)Psychological distress (yes), n (%)
0.18.067.5 (6.1)6.5 (5.9)Psychological distressa, mean (SD)
Self-management skillsb, mean (SD)
0.14.123.2 (0.6)3.3 (0.6)Health-directed behavior
0.18.053.1 (0.5)3.2 (0.5)Positive and active engagement in life
0.05.623.1 (0.4)3.0 (0.4)Self-monitoring and insight
0.04.663.3 (0.5)3.3 (0.5)Constructive attitudes and approaches
0.09.333.0 (0.5)2.9 (0.5)Skill and technique acquisition
0.03.773.2 (0.5)3.2 (0.5)Social integration and support
0.06.543.3 (0.4)3.3 (0.4)Health services navigation
0.25.011.9 (0.6)1.8 (0.5)Emotional distress
.29Satisfaction with overall information provision, n (%)




27 (11.8)41 (18.1)Very satisfied
aScale 0-42; a higher score indicates more psychological distress.
bScale 1-4; higher scores indicate better status or self-management, except for emotional distress, in which higher scores indicate higher distress.
Discussion
Principal Findings
This reach analysis among RCT participants within a
population-based sample showed a selective reach with an
underrepresentation of older patients, women, and those with
a medium to low level of education. In addition, our RCT
participants may represent individuals with relatively better
psychological well-being as scores for emotional distress were
lower in this group.
Approximately a quarter of the population-based sample of
patients with lymphoma and CLL were assessed to be not
eligible for the study for various reasons (eg, deceased, severe
psychopathology or cognitive impairment, a different diagnosis
was ultimately made). Among the eligible patients who were
invited to participate, 51% responded and completed a
questionnaire, half of whom completed the web-based
questionnaire and were enrolled in the RCT, resulting in a
participation rate of 25%. This means that only one in four of
all eligible patients actually participated in the RCT. This
participation rate was lower compared with that of an RCT on
the fully automated electronic health (eHealth) application
Oncokompas that supports cancer survivors in their
self-management (48%) [24]. Similar to the patients in our RCT,
patients in the Oncokompas RCT were selected from the
population-based NCR. However, cancer survivors in the
Oncokompas RCT were first invited in an online survey study
on supportive care and eHealth to assess internet use. Their
participation rate was calculated as the number of RCT
participants divided by the number of eligible respondents of
the survey (access to the internet and email address). Thus, their
group of eligible respondents was more selective compared with
our sample. In our sample, only 82% of all respondents used
the internet, and this percentage may be even lower among all
patients invited to participate.
The results of the current study demonstrate that the RCT
participants were younger, more often men, and more often
actively treated compared to nonparticipants. Thus, the sample
of RCT participants may not be representative of the target
population. Therefore, even though the sample size reached the
required number of patients [12], this sample may not be reliable
for drawing conclusions about the target population.
Furthermore, the effects of the intervention on the target
population may be different from the effects that were found in
the RCT sample [10,25].
These results also provide information about the response rate
of observational research, which was 51%. This is comparable
with response rates from other population-based studies on
quality of life among lymphoma survivors in Germany (54.7%)
[26] and the United States (54.8%) [27]. However, the current
response rate is lower compared with that reported from earlier
observational research within our study group at approximately
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80%, despite similar patients and recruitment procedures [28].
This might be explained by the knowledge that the more
information that is disclosed about the study—which is
inherently more for an RCT than for observational research—the
higher the proportion of nonrespondents [29]. Patients received
abundant information along with the invitation, especially about
participation in an RCT and randomization. The amount of
information, as well as the knowledge of being randomized
when completing a web-based questionnaire, may have deterred
patients from participating. In addition, the type of intervention
may have influenced the participation rate, as the majority of
patients did not have problems with emotional adjustment to
having cancer and therefore may have been less interested in a
self-management intervention. Another explanation may be
related to the fact that participation and response rates for
health-related research have been declining over the past several
years [30,31], and potential participants are faced with an
increasing number of requests to participate in studies. This
may result in patients refusing to participate in all studies [32].
We further compared the characteristics of RCT participants
with those of paper respondents. RCT participants, who
completed the web-based questionnaire, were younger, more
often men, and more highly educated than the paper respondents,
which are similar to the characteristics from previous
observational studies within our study group [33,34]. Highly
educated patients more often display prosocial behavior than
patients with lower levels of education, and therefore the former
group may be more likely to participate in an RCT for altruistic
reasons [35]. In addition to differences in sociodemographic
characteristics, RCT participants reported lower scores related
to neuroticism and higher scores related to openness than paper
respondents. In addition, information preferences slightly
differed between RCT and paper respondents, as RCT
participants more often wanted to receive all available
information on their disease. RCT participants also more often
reported using the internet. To complete a web-based
questionnaire, and subsequently be enrolled in a web-based
self-management intervention RCT, patients must not only be
able to use a computer but also be sufficiently skilled in
browsing the internet [33]. Although there seems to be a trend
of older individuals becoming more active online [33,36], there
is still a subgroup of patients who do not use the internet and
thus have no access to a web-based questionnaire or
internet-based intervention.
Despite these various differences between RCT participants and
paper participants, baseline scores on self-management skills,
satisfaction with information provision, and psychological
distress appeared to be comparable between these groups,
although scores for emotional distress were slightly lower among
RCT participants.
Strengths
The strengths of this study include its unique setting. As patients
were recruited from the population-based NCR, we had
information on sociodemographic and clinical characteristics
of both RCT participants and nonparticipants. In addition, as
the RCT was embedded in the PROFILES registry, we were
able to assess differences between RCT participants and paper
respondents on sociodemographic and clinical characteristics,
in addition to personality traits, information preferences, and
baseline psychological distress, self-management skills, and
satisfaction with information provision (ie, RCT outcome
variables). This information provided the opportunity to
determine both the reach and generalizability of the RCT
sample.
Limitations
The current study has some limitations. Although information
regarding sociodemographic and clinical characteristics of
nonparticipants was available, we did not have information
about nonparticipants’ reasons for declining participation or
their physical and psychological health. Therefore, it remains
unclear whether the physical and psychological health of RCT
participants is similar to that of nonparticipants. In a previous
study that assessed the generalizability of the results of
observational research among cancer survivors by comparing
characteristics of participants and nonparticipants, sensitivity
analysis demonstrated that quality of life might be lower among
nonparticipants [34]. As RCT participants may have a
systematically higher quality of life or report fewer symptoms
compared with nonparticipants, observed outcomes may
represent a group of healthier patients with better outcomes.
This may lead to circumspection in generalizing the results of
an RCT to the target population. It is important to keep this in
mind when interpreting RCT results that may only represent a
minority of the target population.
Conclusions
The participation rate in the RCT was 25%. RCT participants
may be not representative of the target population owing to
different sociodemographic and clinical characteristics. RCT
results should be considered with caution, as RCT participants
represent a minority of the target population, and may actually
be those least in need of the intervention.
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